Research advances in primary biliary cholangitis with hyperlipidemia / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 221-224, 2021.
Article
in Zh
| WPRIM
| ID: wpr-862575
Responsible library:
WPRO
ABSTRACT
Dyslipidemia is one of the most common complications of primary biliary cholangitis (PBC). This article reviews the latest research on lipid profile, the risk of cardiovascular diseases, and treatment of PBC with hyperlipidemia. Different from other liver diseases, PBC with hyperlipidemia has a unique lipid profile, which changes dynamically with disease progression. It is generally not considered that there are increased risks of atherosclerosis and cardiovascular disease. For those who have indications for treatment, statins are recommended as the first choice. In the future, more in-depth systematic studies are needed to clarify its diagnosis, treatment, and management processes.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Journal of Clinical Hepatology
Year:
2021
Document type:
Article